31 Mar 2021
Assets13.93
Total Income40.72
Profit After Tax3.13
NET Worth4.74
Reserves and Surplus4.46
Total Borrowing1.37
At a glance
Updated 2026-09-14Amkay Products is a SME IPO with an issue size of ₹12.61 crore, proposed for listing on BSE SME. The issue structure includes a fresh issue of ₹11.95 crore.
Issue details
Listing atBSE SME
Issue typeBook Build Issue
Issue size₹12.61 Cr
Fresh issue₹11.95 Cr
Face value₹10
Price band₹52.00–₹55.00
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding Capital Expenditure towards installation of additional Machinery | ₹0.50 Cr |
| To meet working capital requirements | ₹8.00 Cr |
| General Corporate Purpose | ₹2.59 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue23.86₹ Cr · -15.5% vs prior year
PAT2.15₹ Cr · +42.4% vs prior year
Assets18.88₹ Cr · +20.7% vs prior year
Net Worth9.87₹ Cr · +27.8% vs prior year
Borrowing4.76₹ Cr · +1.3% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2022
Assets15.81
Total Income36.79
Profit After Tax1.47
NET Worth6.21
Reserves and Surplus5.93
Total Borrowing4.34
31 Mar 2023
Assets15.64
Total Income28.25
Profit After Tax1.51
NET Worth7.72
Reserves and Surplus7.44
Total Borrowing4.70
31 Dec 2023
Assets18.88
Total Income23.86
Profit After Tax2.15
NET Worth9.87
Reserves and Surplus3.51
Total Borrowing4.76
KPIs
| KPI | Dec 31, 2024 |
|---|---|
| ROE | 24.49% |
| ROCE | 21.54% |
| Debt / Equity | 0.48% |
| RoNW | 21.82% |
| PAT Margin | 9.47% |
| Price to Book Value | 3.55 |
Valuation & shareholding
Pre-IPO EPS2.37
Post-IPO EPS3.32
Pre-IPO P/E23.18
Post-IPO P/E16.58
Promoter holding pre99.89%
Promoter holding post73.44%
Market cap₹47.61 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Amkay Products IPO | — | 16.58 x | — | — |
| Abh Healthcare IPO | — | 20.69 x | — | — |
| Credent Connect IPO | — | 153.66 x | — | — |
| H. R. IPO | — | 17.53 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Book Running Lead Manager fees | ₹0.25 Cr |
| Fees Payable to Registrar to the Issue | ₹0.01 Cr |
| Fees Payable for Advertising and Publishing Expenses | ₹0.05 Cr |
| Fees Payable to Regulators including Stock Exchanges | ₹0.12 Cr |
| Payment for Printing & Stationery, Postage, etc. | ₹0.03 Cr |
| Fees Payable to Auditor, Legal Advisors and other Professionals | ₹0.08 Cr |
| Others, if any (Fees payable for Marketing & distribution expenses, Selling Commission, Brokerage, depositories, secretarial, advisors, consultancy, peer review auditors, Processing Fees, Underwriting fees and Miscellaneous Expenses) | ₹0.98 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Hem Securities Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-14.
IPO UPDATE ALERTS
Register for IPO Updates →Track Amkay Products without missing an update
Register for subscription, GMP, allotment and listing notifications.